Stocks
Vertex Pharmaceuticals IncorporatedVRTX
NASDAQHealthcareBiotechnology$469.34-1.84%
A biotechnology company focused on developing therapies for serious genetic diseases, with a dominant portfolio of treatments for cystic fibrosis that generate the majority of its revenue. The company is expanding its pipeline into areas such as gene-editing therapies, pain management, and other rar...
Market Cap: $119.2B52W Range: $362.50 – $517.20
Congressional Interest in Vertex Pharmaceuticals Incorporated (VRTX)
1 member of Congress has disclosed 6 trades in Vertex Pharmaceuticals Incorporated (VRTX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 3 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
1
Buys
3
Sells
3
Who in Congress Is Trading VRTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-01-23 | David P. Roe | buy | $1K – $15K |
| 2014-01-23 | David P. Roe | buy | $1K – $15K |